Arbor Therapeutics, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arbor Therapeutics, LLC.The latest application filed is for "acid-labile lipophilic prodrugs of cancer chemotherapeutic agents".

Company Profile

1.12.12

Arbor Therapeutics, LLC - Etta MS US
Arbor Therapeutics, LLC - Etla MS US
Arbor Therapeutics, LLC -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents Grant 10,172,957 - McChesney , et al. J	2019-01-08
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation Grant 10,064,823 - McChesney , et al. September 4, 2	2018-09-04
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents App 20180161439 - McChesney; James D. ; et al.	2018-06-14
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents Grant 9,889,201 - McChesney , et al. February 13, 2	2018-02-13
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation App 20170042815 - McChesney; James D. ; et al.	2017-02-16
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents App 20160354475 - McChesney; James D. ; et al.	2016-12-08
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation Grant 9,468,603 - McChesney , et al. October 18, 2	2016-10-18
Taxane And Abeo-taxane Analogs App 20160176894 - McChesney; James D. ; et al.	2016-06-23
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents Grant 9,339,555 - McChesney , et al. May 17, 2	2016-05-17
Taxane and abeo-taxane analogs Grant 9,227,983 - McChesney , et al. January 5, 2	2016-01-05
Taxane And Abeo-taxane Analogs App 20150158880 - McChesney; James D. ; et al.	2015-06-11
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation App 20150079189 - McChesney; James D. ; et al.	2015-03-19
Taxane and abeo-taxane analogs Grant 8,912,229 - McChesney , et al. December 16, 2	2014-12-16
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents App 20140249213 - McChesney; James D. ; et al.	2014-09-04
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents Grant 8,716,328 - McChesney , et al. May 6, 2	2014-05-06
Taxane and Abeo-Taxane Analogs App 20140093503 - McChesney; James D. ; et al.	2014-04-03
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents App 20130303601 - McChesney; James D. ; et al.	2013-11-14
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents Grant 8,440,714 - McChesney , et al. May 14, 2	2013-05-14
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents App 20120309819 - McChesney; James D. ; et al.	2012-12-06

Company Registrations

NCAGE Code	6KJT0	ARBOR THERAPEUTICS, LLC
CAGE Code	6KJT0	ARBOR THERAPEUTICS, LLC
DUNS	969968226	Arbor Therapeutics, LLC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.